FR2751412B3 - Methodes de diagnostic in vitro de maladies neurodegeneratives et trousses pour la mise en oeuvre de ces methodes - Google Patents

Methodes de diagnostic in vitro de maladies neurodegeneratives et trousses pour la mise en oeuvre de ces methodes

Info

Publication number
FR2751412B3
FR2751412B3 FR9608941A FR9608941A FR2751412B3 FR 2751412 B3 FR2751412 B3 FR 2751412B3 FR 9608941 A FR9608941 A FR 9608941A FR 9608941 A FR9608941 A FR 9608941A FR 2751412 B3 FR2751412 B3 FR 2751412B3
Authority
FR
France
Prior art keywords
methods
kits
implementation
neurodegenerative diseases
vitro diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9608941A
Other languages
English (en)
Other versions
FR2751412A1 (fr
Inventor
Denis Barritault
Marie Claude Tournaire
Michel Troupel
Claire Banissi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Valbiofrance Ste
Original Assignee
Valbiofrance Ste
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valbiofrance Ste filed Critical Valbiofrance Ste
Priority to FR9608941A priority Critical patent/FR2751412B3/fr
Priority to PCT/FR1997/001333 priority patent/WO1998003869A1/fr
Priority to JP10506643A priority patent/JP2000517048A/ja
Priority to AU37739/97A priority patent/AU3773997A/en
Priority to CA 2260829 priority patent/CA2260829A1/fr
Priority to EP97934586A priority patent/EP0912893A1/fr
Publication of FR2751412A1 publication Critical patent/FR2751412A1/fr
Application granted granted Critical
Publication of FR2751412B3 publication Critical patent/FR2751412B3/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9608941A 1996-07-17 1996-07-17 Methodes de diagnostic in vitro de maladies neurodegeneratives et trousses pour la mise en oeuvre de ces methodes Expired - Fee Related FR2751412B3 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR9608941A FR2751412B3 (fr) 1996-07-17 1996-07-17 Methodes de diagnostic in vitro de maladies neurodegeneratives et trousses pour la mise en oeuvre de ces methodes
PCT/FR1997/001333 WO1998003869A1 (fr) 1996-07-17 1997-07-17 Methodes de diagnostic in vitro de maladies neurodegeneratives et trousses pour la mise en oeuvre de ces methodes
JP10506643A JP2000517048A (ja) 1996-07-17 1997-07-17 神経退行変性病理のｉｎ ｖｉｔｒｏ診断方法及びこれらの方法を実施するためのキット
AU37739/97A AU3773997A (en) 1996-07-17 1997-07-17 Methods for diagnosing neurodegenerative diseases (in vitro), and kits therefor
CA 2260829 CA2260829A1 (fr) 1996-07-17 1997-07-17 Methodes de diagnostic in vitro de maladies neurodegeneratives et trousses pour la mise en oeuvre de ces methodes
EP97934586A EP0912893A1 (fr) 1996-07-17 1997-07-17 METHODES DE DIAGNOSTIC $i(IN VITRO) DE MALADIES NEURODEGENERATIVES ET TROUSSES POUR LA MISE EN OEUVRE DE CES METHODES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9608941A FR2751412B3 (fr) 1996-07-17 1996-07-17 Methodes de diagnostic in vitro de maladies neurodegeneratives et trousses pour la mise en oeuvre de ces methodes

Publications (2)

Publication Number Publication Date
FR2751412A1 FR2751412A1 (fr) 1998-01-23
FR2751412B3 true FR2751412B3 (fr) 1998-09-25

Family

ID=9494143

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9608941A Expired - Fee Related FR2751412B3 (fr) 1996-07-17 1996-07-17 Methodes de diagnostic in vitro de maladies neurodegeneratives et trousses pour la mise en oeuvre de ces methodes

Country Status (6)

Country Link
EP (1) EP0912893A1 (fr)
JP (1) JP2000517048A (fr)
AU (1) AU3773997A (fr)
CA (1) CA2260829A1 (fr)
FR (1) FR2751412B3 (fr)
WO (1) WO1998003869A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234814A (en) * 1989-06-01 1993-08-10 Du Pont Merck Pharmaceutical Company Diagnostic assay for alzheimer's disease
BR9205811A (pt) * 1991-03-28 1994-06-28 Pfizer Derivados heterociclicos de aminas ciclicas
US5656447A (en) * 1993-07-30 1997-08-12 Georgetown University Antibodies specific to quinolinic acid
WO1995005604A2 (fr) * 1993-08-13 1995-02-23 Molecular Geriatrics Corporation Procedes de diagnostic de la maladie d'alzheimer

Also Published As

Publication number Publication date
FR2751412A1 (fr) 1998-01-23
AU3773997A (en) 1998-02-10
WO1998003869A1 (fr) 1998-01-29
CA2260829A1 (fr) 1998-01-29
EP0912893A1 (fr) 1999-05-06
JP2000517048A (ja) 2000-12-19

Similar Documents

Publication Publication Date Title
IT1283010B1 (it) Complesso metallocenico supportato e procedimento per la sua prepa- razione
AU5212199A (en) Methods and kits for diagnosing and determination of the predisposition of diseases
DE69635174D1 (de) Nichtinvasive Vorrichtung zur Blutuntersuchung
IS2505B (is) Speglunarskuggaefni, sem helst lengi í blóði, til sjúkdómsgreininga
EP0791177A4 (fr) Methode permettant de diagnostiquer des troubles thrombotiques
DE59602414D1 (de) MR-Verfahren und MR-Gerät zur Durchführung des Verfahrens
DE69635252D1 (de) System und Verfahren mit wiederverhandelten Bitrateservice
FR2781668B1 (fr) Procede de traitement de la peau et patch pour la mise en oeuvre du procede
GB9624411D0 (en) Diagnosis of prion diseases
ZA964893B (en) Early diagnostic test
IL123834A0 (en) Diagnostic method and kit for determining rh blood group genotype
FR2780161B1 (fr) Procede de diagnostic precoce du cancer base sur la recherche d'auto-anticorps diriges contre la proteine csk et trousse pour sa mise en oeuvre
HUP9902100A3 (en) Process for testing the operation of fittings
FR2751412B3 (fr) Methodes de diagnostic in vitro de maladies neurodegeneratives et trousses pour la mise en oeuvre de ces methodes
GB9503109D0 (en) Diagnostic test tube and kits
DE69712982T2 (de) Mechanismus zur Prüfung und Diagnose
FI974424A0 (fi) Varhainen diagnostinen testi
FR2731351B1 (fr) Composition pour le lissage de la peau et procede pour la preparation de cette composition
DE69731807D1 (de) Prozess für die präparation von daunorubicin
FR2766927B1 (fr) Methodes et kits pour le diagnostic de la maladie d'alzheimer
BR9507125A (pt) Teste e kit para o diagnóstico de esquizofrenia em um indivíduo
BR9708461A (pt) Derivados de butadieno e processos para sua preparação
NZ319260A (en) Method for the diagnosis of coeliac disease
NO974679D0 (no) Fremgangsmåte og forsökssett for diagnostikk og for bestemmelse av risiko for progresjon derav
DE29614704U1 (de) Vorrichtung zur Testung neuropsychologischer Merkmale und zur Diagnosefindung sowie zur Kennzeichnung des Verlaufs psychiatrischer Erkrankungen

Legal Events

Date Code Title Description
ST Notification of lapse